Academic literature on the topic 'Novel CRC therapies'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Novel CRC therapies.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Novel CRC therapies"
Krauss, John, and Christine Veenstra. "Emerging Systemic Therapies for Colorectal Cancer." Clinics in Colon and Rectal Surgery 31, no. 03 (April 1, 2018): 179–91. http://dx.doi.org/10.1055/s-0037-1602238.
Full textTorres Adorno, Angie M., Julie Fong, Jeff Grein, Wendy Blumenschein, Danye Cheng, Katherine Porth, Peng Yang, Jennifer Yearley, Amy Beebe, and Barbara Joyce-Shaikh. "Development of a Humanized 3D Tumor Spheroid Models and Discovery of Effective Immunotherapy Strategies Against Resistant Microsatellite Stable Colorectal Cancers." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 241.9. http://dx.doi.org/10.4049/jimmunol.204.supp.241.9.
Full textBitar, Lynn, Joseph Zouein, Fady Gh Haddad, Roland Eid, and Hampig R. Kourie. "HER2 in metastatic colorectal cancer: a new to target to remember." Biomarkers in Medicine 15, no. 2 (February 2021): 135–38. http://dx.doi.org/10.2217/bmm-2020-0491.
Full textPerillo, Federica, Chiara Amoroso, Francesco Strati, Maria Rita Giuffrè, Angélica Díaz-Basabe, Georgia Lattanzi, and Federica Facciotti. "Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes." International Journal of Molecular Sciences 21, no. 15 (July 29, 2020): 5389. http://dx.doi.org/10.3390/ijms21155389.
Full textMedin, Caroline, Michael K. Turgeon, Jessica M. Keilson, Bhakti Dwivedi, Cameron Herting, Shishir K. Maithel, and Gregory B. Lesinski. "High-risk gene expression in colorectal liver metastasis: Potential for novel therapies." Journal of Clinical Oncology 40, no. 4_suppl (February 1, 2022): 147. http://dx.doi.org/10.1200/jco.2022.40.4_suppl.147.
Full textDe Pauw, Ines, Filip Lardon, Jolien Van den Bossche, Hasan Baysal, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, and An Wouters. "Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib." Cancers 11, no. 1 (January 15, 2019): 98. http://dx.doi.org/10.3390/cancers11010098.
Full textVekic, Jelena, Aleksandra Zeljkovic, Aleksandra Stefanovic, Rosaria Vincenza Giglio, Marcello Ciaccio, and Manfredi Rizzo. "Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents." International Journal of Molecular Sciences 22, no. 22 (November 17, 2021): 12409. http://dx.doi.org/10.3390/ijms222212409.
Full textHu, Bangli, Yixin Yin, Siqi Li, and Xianwen Guo. "Insights on Ferroptosis and Colorectal Cancer: Progress and Updates." Molecules 28, no. 1 (December 28, 2022): 243. http://dx.doi.org/10.3390/molecules28010243.
Full textNaydenov, Nayden, Susana Lechuga, Emina Huang, and Andrei Ivanov. "Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer." Cancers 13, no. 4 (February 11, 2021): 741. http://dx.doi.org/10.3390/cancers13040741.
Full textKang, Bo, Xiaobing Zhang, Weibing Wang, Shiqi She, Wenjie Chen, Cheng Chen, Yisha Wang, Xiaoyun Pan, Ouyuan Xu, and Yingjie Wang. "The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer." Cancers 14, no. 23 (November 23, 2022): 5747. http://dx.doi.org/10.3390/cancers14235747.
Full textDissertations / Theses on the topic "Novel CRC therapies"
Caras, James William. "Emulation and induction of cytotoxic immunity : immunotoxin therapies for AIDS and novel antiviral vaccines /." Digital version accessible at:, 1999. http://wwwlib.umi.com/cr/utexas/main.
Full textBooks on the topic "Novel CRC therapies"
Mukherji, Deborah, Aurelius Omlin, Carmel Pezaro, and Johann De Bono. Novel therapies and emerging strategies for the treatment of patients with castration-resistant prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0069.
Full textBook chapters on the topic "Novel CRC therapies"
João Pissarra, Ana, Catarina Abreu, André Mansinho, Ana Lúcia Costa, Sara Dâmaso, Soraia Lobo-Martins, Marta Martins, and Luís Costa. "Landscape of Current Targeted Therapies for Advanced Colorectal Cancer." In Colorectal Cancer. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.93978.
Full textConference papers on the topic "Novel CRC therapies"
Puig, T., A. Urruticoechea, G. Oliveras, H. Aguilar, C. Turrado, S. Cufí, S. Ortega-Gutiérrez, B. Benhamú, M. López-Rodríguez, and R. Colomer. "MG28, a novel fatty acid synthase inhibitor, overcomes resistance to anti-HER therapies in breast cancer." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-2143.
Full textSethi, S., A. Ahmad, R. Ali-Fehmi, S. Mittal, G. Dyson, and F. Sarkar. "Abstract P4-15-07: MicroRNA signature of breast cancer brain metastasis for novel targeted therapies." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-p4-15-07.
Full textSoldi, R., A. Gustafson, H. Zhu, R. Wilcox, B. Welm, A. Spira, S. Jeffrey, and A. Bild. "A Phenotype-Based Model for Rational Selection of Novel Targeted Therapies in Treating Aggressive Breast Cancer." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-2007.
Full textWali, VB, CG Langdon, MA Held, JT Platt, A. Safonov, B. Aktas, DF Stern, L. Pusztai, and C. Hatzis. "Abstract P6-13-06: Novel combination therapies for triple negative breast cancer identified by high-throughput screening." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p6-13-06.
Full textCoughlin, Christina M. "Abstract IA21: Immune mobilizing TCR therapies against cancer (ImmTAC): A novel class of antigen-specific tumor immunotherapy." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-ia21.
Full textGu, G., KR Covington, NM Fernandez, S. Ando’, and SAW Fuqua. "P1-12-04: EBP50 – A Novel Biomarker for Resistance to Endocrine and HER2−Targeted Therapies in Breast Cancer." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-p1-12-04.
Full textDavis, Joanne, Kylie Mason, Chia Sharpe, Rachel Koldej, Brendon Chua, David Jackson, Paul Neeson, Constantine Tam, and David Ritchie. "Abstract B054: Can CLL-B cells treated with novel combination therapies be used to promote anti-CLL immune responses?" In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b054.
Full text